The Pharm So Hard Emergency Medicine & Hospital Pharmacy Podcast

Episode 115. Impact of EM CPP-driven sepsis antibiotic interventions with Taylor Cason

This episode of the Pharm So Hard podcast discusses the use of clinical pharmacy practitioners in the emergency room and their impact on sepsis antibiotic interventions author by Aubrie Hammond, Regan Porter, Taylor Cason, et al. The study found that the involvement of EMCPPs significantly improved the selection and timing of antibiotic administration in septic patients. The pharmacist-driven protocol improved the rate of appropriate antibiotic selection from 57% to 86% and reduced the time to administration by 64 minutes. The study also highlighted areas where antibiotic selection could be further improved, such as UTIs and intra-abdominal infections. The role of pharmacists in optimizing treatment time and expanding the pharmacist-driven sepsis management model was also discussed.

Episode 114. PharmD Lit Highlight: Risk of Arrhythmia in post-resuscitative shock after OHCA with Epi vs Norepi

In this episode of the Pharm So Hard Podcast's PharmD Literature Highlight Series, host Jimmy Pruitt, PharmD, BCPS, BCCCP, BCEMP discusses the study "Risk of arrhythmia in post-resuscitative shock after out-of-hospital cardiac arrest with epinephrine versus norepinephrine" by Sarah Normand, Pharm.D., Courtney Matthews, Pharm.D., Caitlin S. Brown, Pharm.D., Alicia E. Mattson, Pharm.D., Kristin C. Mara, M.S., Fernanda Bellolio, M.D., M.S., and Erin D. Wieruszewski, Pharm.D.

Episode 113. Timing Matters: Delving into Prothrombin Complex Concentrate with Authors Townsend and Gilbert

Full TextPubMedIn this episode of the Pharm So Hard podcast, host Jimmy Pruitt interviews Brock Townsend and Brian Gilbert about their study on the impact of time to administration of four-factor PCC for patients with warfarin-associated intracranial hemorrhage. The study was a retrospective observational single-center study performed at a large community teaching hospital. The authors stratified patients into three groups based on time from diagnosis to administration of four-factor PCC. The study found no significant differences in outcomes, such as hemostasis achievement, hospital mortality, length of stay, and adverse effects. The authors emphasize the need for more data and personalized protocols for anticoagulation-related ICH.
Takeaways
The study found no significant differences in outcomes based on time to administration of four-factor PCC for patients with warfarin-associated intracranial hemorrhage. More data is needed to determine the optimal time to administer four-factor PCC and develop personalized protocols for anticoagulation-related ICH.
Standardization of radiologists' interpretations and reporting of CT scans is important for future studies in this area.
The study highlights the importance of resident research in answering important clinical questions.
Pharmacists and healthcare professionals should continue to strive for personalized medicine and individualized care for patients with anticoagulation-related ICH.

Episode 112. The Story of EMPoweRx 24

In this episode of The Pharm So Hard Podcast, host Jimmy Pruitt, PharmD, BCPS, BCCCP, alongside guests Robert O'Connell, PharmD, BCCCP, BCEMP, Louisa Sullivan, PharmD, BCPS, BCEMP, Mark Mixon, PharmD, BCPS, BCIDP, BCCCP, and Joshua Senn, PharmD, BCPS, share their experiences at last year's EMPoweRx conference. As they gear up for this year's conference, gain exclusive insights into their preparations and aspirations, offering a glimpse into their pursuit of excellence in pharmacy practice.

Episode 111. Pulse Check! Kyle Stupca’s Study on Esmolol & Dose-Capped Epi

This Pharm So Hard episode titled "Pulse Check! Kyle Stupca's Study on Esmolol & Dose-Capped Epi" is a deep dive into the innovative research conducted by Kyle Stupca on emergency cardiac care. The episode hosted by Jimmy Pruitt aims to explore Stupca's groundbreaking study which focuses on the use of Esmolol and dose-capped epinephrine in treating life-threatening cardiac arrhythmias like ventricular fibrillation and pulseless ventricular tachycardia. The discussion covers Stupca's personal journey and motivations in emergency medicine research, delves into the specifics of his study's methodology, findings, and the challenges faced during research. A significant part of the episode is dedicated to discussing the practical implications of these findings for emergency cardiac care and envisaging the future of this field with unlimited research resources. This episode is designed to enlighten healthcare professionals, particularly pharmacists and physicians, about the evolving role of pharmacology in emergency medical scenarios, emphasizing the critical impact of research in this domain.

Episode 109. STREAM-2 Study Journal Club with Nick Servati and Alex Cruz Pabon

In this episode of the Pharm So Hard Podcast, Jimmy L. Pruitt III, PharmD, BCPS, BCCCP together with Alexandra Cruz Pabón, PharmD and Nicholas Servati, PharmD, BCCP discuss the STREAM-2 Study Journal Club.

Episode 110. The use of Methylene Blue for Refractory Hypotension with Rosa Malloy-Post, MD

In this episode of the Pharm So Hard Podcast, Jimmy L. Pruitt III, PharmD, BCPS, BCCCP together with Rosa Malloy-Post, MD discuss the use of Methylene Blue for Refractory Hypotension.

Episode 108. Discussing DEI, Transparency, and Advocacy in Pharmacy Organizations

In this episode of the Pharm So Hard Podcast, Jimmy L. Pruitt III, PharmD, BCPS, BCCCP together with Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES and Sarah Cummins, PharmD discuss everything about DEI, Transparency, and Advocacy in Pharmacy Organizations.

Episode 107. Bupropion Toxicity with Thom Maciulewicz

In this episode of the Pharm So Hard Podcast, Jimmy L. Pruitt III, PharmD, BCPS, BCCCP together with Thom Maciulewicz, PharmD, BCPS talk everything about Bupropion.

Episode 106. Toxic Alcohols with Thom Maciulewicz

In this episode of the Pharm So Hard Podcast, Jimmy L. Pruitt III, PharmD, BCPS, BCCCP together with Thom Maciulewicz, PharmD, BCPS talk everything about Toxic Alcohols.